Diseases culminating in photoreceptor loss are a major cause of untreatable blindness. Transplantation of rod photoreceptors is feasible, provided donor cells are at an appropriate stage of development when transplanted. Nevertheless, the proportion of cells that integrate into the recipient outer nuclear layer (ONL) is low. The outer limiting membrane (OLM), formed by adherens junctions between Müller glia and photoreceptors, may impede transplanted cells from migrating into the recipient ONL. Adaptor proteins such as Crumbs homologue 1 (Crb1) and zona occludins (ZO-1) are essential for localization of the OLM adherens junctions. We investigated whether targeted disruption of these proteins enhances donor cell integration. Transplantation of rod precursors in wild-type mice achieved 949 ± 141 integrated cells. By contrast, integration is significantly higher when rod precursors are transplanted into Crb1 rd8/rd8 mice, a model of retinitis pigmentosa and Lebers congenital amaurosis that lacks functional CRB1 protein and displays disruption of the OLM (7,819 ± 1,297; maximum 15,721 cells). We next used small interfering (si)RNA to transiently reduce the expression of ZO-1 and generate a reversible disruption of the OLM. ZO-1 knockdown resulted in similar, significantly improved, integration of transplanted cells in wild-type mice (7,037 ± 1,293; maximum 11,965 cells). Finally, as the OLM remains largely intact in many retinal disorders, we tested whether transient ZO-1 knockdown increased integration in a model of retinitis pigmentosa, the rho −/− mouse; donor cell integration was significantly increased from 313 ± 58 cells without treatment to 919 ± 198 cells after ZO-1 knockdown. This study shows that targeted disruption of OLM junctional proteins enhances integration in the wild-type and degenerating retina and may be a useful approach for developing photoreceptor transplantation strategies.
INTRODUCTION
functionally integrate are postmitotic rod photoreceptor precursors, rather than stem/progenitor cells (24). Thus, rod photoreceptor transplantation is feasible, but the deMost retinal degenerative diseases culminate in the loss of photoreceptors. Cell transplantation offers a stratvelopmental stage of the donor cell appears critical to its success. Moreover, transplantation efficiency is low. egy to replace these cells and restore visual function. Both adult wild-type and diseased retinae are capable Migration of transplanted murine neural progenitor cells occurs into the immature opossum retina, but is lost with of integrating transplanted cells, and these cells develop unambiguous characteristics of mature photoreceptors increasing maturity (34, 49) , while in the adult retina, extensive migration is restricted to severely degenerated (3, 21, 24) . By using a fluorescent marker linked to the promoter sequence of Nrl, a transcription factor expressed retina (55) or to areas of significant physical disruption (15, 56) . This suggests that barriers exist within the rein rods shortly after terminal mitosis (2), we showed that the cells that possess this capacity to migrate and cipient retina that prevents greater numbers of cells from integrating (40) . The outer limiting membrane (OLM) a concentration of 200,000 cells/µl in sterile EBSS and DNase (0.005%). Surgery was performed as previously may be one such barrier.
The OLM comprises a series of zonula adherens described (24). Recipient mice were anesthetised with an intraperitoneal injection of 0.2 ml of a mixture of junctional complexes between photoreceptors and Mül-ler glia (Fig. 1A ) and is first discernible by postnatal Dormitor (1 mg/ml medetomidine hydrochloride, Pfizer Pharmaceuticals, Kent UK), ketamine (100 mg/ml, Fort day (P) 5 in the mouse (47) . Adherens junctions are transmembrane cadherin-catenin complexes that mediDodge Animal Health, Southampton, UK), and sterile water for injections in the ratio of 5:3:42. Cells were ate cell-cell adhesion. These junctions interact with a cytoplasmic plaque comprised of adaptor proteins, intransplanted via a single injection (1 µl), made at an oblique angle through the superior sclera into the subretcluding, among others, Crumbs homologue 1 (Crb1) and zonula occludins 1 (ZO-1), which is essential for their inal space, using a sterile 34-gauge hypodermic needle (Hamilton, Switzerland) and injected slowly to produce maintenance. Pharmacological interference or genetic disruption of a number of components of the adherens a standard and reproducible retinal detachment in the superior hemisphere (in the same region as the siRNA junction and/or the supporting scaffold leads to significant impairment in OLM integrity [see (48, 50) ].
injection, where appropriate) (Fig. 1B) . The needle was slowly withdrawn, leading to a self-sealing of the wound Previously, we showed a twofold increase in the number of integrated cells after intravitreal administratunnel. tion of a pharmacological toxin, alpha-aminoadipic acid Preparation and Administration of siRNAs (AAA), prior to cell transplantation (51). AAA disrupts Müller glial function and, indirectly, OLM integrity in
Targeting siRNA against ZO-1 was generated using the sequence 5′-AAGATAGTTTGGCAGCAAGAG-3′ wild-type mice, suggesting that reduced OLM integrity enhances cell integration. However, AAA administration (Invitrogen, UK), as reported previously (39). The siRNA was resuspended and diluted to the appropriate concenwas recently reported to cause Müller cells to dedifferentiate and migrate into the ONL (43), and our previous tration in sterile buffer containing oligofectamine using RNAase-free plasticware. Controls comprised a 1-µl instudy did not exclude the possibility that these or other effects of AAA enhance integration. Here, we directly jection of buffer/oligofectamine containing an equivalent concentration of a proven nontargeting siRNA (Alltest the hypothesis that the OLM is a barrier to transplanted cell migration and integration by investigating Stars negative control siRNA; Cat. No. 1027281; Qiagen, UK), or sterile buffer alone (vehicle). siRNAs were inintegration in models with targeted genetic and molecular disruption of specific proteins of the OLM junctional troduced by subretinal injection to the superior retina 48 h prior to cell transplantation, unless stated otherwise. complex. We show that it is possible to induce a transient disruption of OLM integrity using RNA interferImmunohistochemistry and Histology ence. When combined with cell transplantation, these strategies lead to significant increases in cell integration Eyes were dissected out, leaving the superior rectus muscle in place to provide a landmark for the superior in both wild-type mice and, importantly, in models of retinal degeneration.
retina, and placed in 4% (for cell counting) or 1% (immunohistochemistry) paraformaldehyde (PFA) in PBS MATERIALS AND METHODS for 1 h. Eye cups were prepared by removing the front Animals of the eye, including the lens, before being cryoprotected in 20% sucrose/PBS, cryo-embedded in OCT (Tis-C57/Bl6 (Harlan, UK), Nrl.gfp +/+ (A. Swaroop, UnisueTek), and cut as transverse sections 20 µm thick. versity of Michigan), Crb1 rd8/rd8 (Jackson Laboratory), Retinal cryosections were air-dried for 15-30 min and rho −/− (P. Humphries, Trinity College Dublin) mice and washed in Tris-buffered saline (TBS). For immunowere maintained in the animal facility at University Colhistochemistry, sections were preblocked in TBS conlege London. Animals were kept on a standard 12-h taining normal goat serum (2%), bovine serum albumin light/dark cycle. All experiments have been conducted (1%), and 0.05% Triton X-100 for 1 h before being inin accordance with the United Kingdom Animals (Sciencubated with primary antibody overnight at 4°C. After tific Procedure) Act of 1986. rinsing with TBS, sections were incubated with secondDissociation of Retinal Cells and Transplantation ary antibody for 2 h at room temperature (RT), rinsed, and counterstained with Hoechst 33342. Negative conDissociated cells were prepared from P4 Nrl.gfp
mice. The use of Nrl.gfp mice provides a genetic marker trols omitted the primary antibody. The following antibodies were used: pancadherin (1:500; rabbit polyclonal; that identifies donor rod photoreceptors. Cells were dissociated using a papain-based kit (Worthington BioSigma, UK); ZO-1 (1:500; rabbit polyclonal; Zymed); β-catenin (1:2000; rabbit polyclonal, Abcam, UK); chemical, Lorne Laboratories, UK) and resuspended at GFAP (1:500; rabbit polyclonal; DAKO); Crb1 (1:100; overnight and Ganzfeld ERGs were obtained simultaneously from both eyes to provide an internal control. kind gift of Jan Wijnholds).
Mice were anesthetized as before and the pupils were Confocal Microscopy dilated using one drop of Tropicamide 1%. Viscotears were placed on each cornea to keep it moistened after Retinal sections were viewed on a confocal microscope (Zeiss LSM510 or Leica SP2), as previously decorneal contact electrodes and midline subdermal reference and ground electrodes were placed. Single flash scribed (24). Images show either single confocal sections or merged projection images of an xyz confocal recordings were obtained at light intensities of 0.001, 0.01, 0.1, 1, 3, 5, and 10 cd s m −1 using a sampling stack through retinal sections, approximately 10 µm thick.
frequency of 5 kHz, a flash duration of 4 ms, and a Electron Microscopy frequency stimulus of 0.5 Hz. Data were recorded from 10 ms before stimulus onset to 400 ms poststimulus. For Mice were sacrificed 48 h after siRNA administration. The eyes were fixed overnight (3% glutaraldehyde/ the first three intensities 10 responses were averaged to obtain the final ERG, whereas for the last two intensities 1% PFA) and then the cornea and lens were removed and the eye cups orientated and processed, as previously 5 responses were averaged. The bandpass filter was set between 0 and 1 kHz. For ERG analysis, the a-and bdescribed (45, 51) . Ultrathin sections were collected on copper grids (100 mesh, Agar Scientific), contrast wave values (a-wave trough to b-wave peak) of the treated eyes were paired with the untreated contralateral stained with 1% uranyl acetate and lead citrate and analyzed using a JEOL 1010 Transmission Electron Microeyes to provide an internal control. This method controls for interanimal variance. scope (80 kV), fitted with a digital camera for image capture.
Statistics Cell Counts
All means are stated ±SEM, unless indicated otherwise. N = number of eyes and n = number of sections Counts of integrated cells were taken 3 weeks after examined, where appropriate. All experiments concerntransplantation using a fluorescence microscope (Obing siRNA injections were conducted as paired experiserver Z.1, Zeiss, UK). No substantial changes were obments, whereby the contralateral eye served as a withinserved in the number of integrated cells between 2 and animal control. Statistical significance was assessed 4 weeks posttransplantation (data not shown). The use using Graphpad Prism 5 software, and applying paired tof the Nrl.gfp mouse as a source of donor cells provides test, ANOVA with Bonferonni's correction for multiple a genetic marker for the identification of rod photorecomparisons, where appropriate. ceptors (2, 26, 41) . Cells were considered to be integrated if the whole cell body was correctly located within the RESULTS outer nuclear layer, and at least one of the following was Increased Integration of Rod Photoreceptors in the visible: spherule synapse, inner/outer processes, inner/ Crb1 rd8/rd8 Mouse, a Model of OLM Disruption outer segments (Fig. 1a ). Animals were omitted from analysis if there was clear evidence of an injection havCrb1 is a protein essential for the formation and localization of the OLM adherens junction and expressed ing been administered intravitreally, rather than subretinally, or if there was an absence of cells in the subretinal by Müller glia (27, 48, 50) . Mutations in the human CRB1 gene cause retinal diseases including retinitis pigspace, which is an indication that reflux of the donor cell suspension had occurred at the time of injection (<5%). mentosa and Lebers congenital amaurosis (23) . The Crb1 rd8/rd8 mouse has a single base deletion in Crb1, Apoptotic Cell Counts which causes a frameshift and premature stop codon, truncating the protein upstream of the transmembrane The total number of apoptotic cells was determined by counting all TUNEL-positive profiles in each layer domain. Loss of functional CRB1 protein affects OLM integrity causing retinal degeneration (27) and provides of the retina in alternate serial sections. Only regions around the site of injection are shown. Apoptosis was a genetic model in which to evaluate the role of the OLM in impeding transplanted cell integration. This natminimal or absent in regions away from the site of detachment.
urally occurring mutant was first described by Mehalow and coworkers (27) , who noted that the OLM displayed Electrophysiology significant fragmentation, as assessed by electron microscopy and immunohistochemistry, apparent from 2 ERGs from injected animals were recorded in a standardized fashion, 7 weeks after treatment using an Esweeks of age.
To determine the impact of OLM disruption in pion E2 system with a ColourDome stimulator (Diagnosys LLC, Lowell, MA). Animals were dark adapted Crb1 rd8/rd8 on transplanted rod photoreceptor cell migra-tion and integration, we transplanted unsorted dissocitivation at each time point (3, 6 , and 12 weeks of age). Glial cell activation is a feature of the degenerating retated P4 neural retinal cells from Nrl.gfp +/+ mice, in which GFP expression is driven by the promoter of Nrl, ina and has been proposed to impede cell migration (13,31). In the wild-type mouse, Crb1 and a second a transcription factor specific for postmitotic rod precursors that persists in adult rods [see (2, 24) for details].
adapter protein, ZO-1, are visualized as a continuous line at the outer margin of the neural retina ( Fig. 2A , B, Cells were injected into the subretinal space of 3-, 6-, and 12-week-old Crb1 rd8/rd8 mice or 6-week-old wildfar right). Conversely, in the neural retina of 3-week-old Crb1 rd8/rd8 mice, CRB1 expression was no longer cortype mice. Three weeks postinjection, the animals were sacrificed and the total number of integrated cells deterrectly located at the OLM, consistent with loss of the transmembrane domain of the nonfunctional protein mined. Cell integration was significantly increased in both the 3-and 6-week-old Crb1 rd8/rd8 recipients, com-( Fig. 2A) , while that of ZO-1 was discontinuous and fragmented ( Fig. 2B ). ZO-1 expression became increaspared with wild-type controls ( Table 1 , Fig. 1C, D) . A maximum of 10,227 and 15,721 integrated cells was obingly disorganized with advancing age, with significant gaps in expression at the OLM by 6 weeks (Fig. 2B ). served in 3-and 6-week-old Crb1 rd8/rd8 mice, respectively. This contrasts with a maximum number of 1,078
Similarly, pancadherin, which labels cadherin cell-cell adhesion molecules, is strongly expressed at the OLM cells in 6-week-old wild-type mice. However, donor cell integration was only twofold higher than wild-type conin wild-type mice (Fig. 2C , far right) but became progressively more diffuse and disorganized over time in trols following transplantation into 12-week-old Crb1 rd8/ the Crb1 rd8/rd8 mouse (Fig. 2C ). Over the same time perd8 recipients, a time when GFAP upregulation is maximal (of the time points studied here).
riod, GFAP, which is expressed by activated glial and astrocyte populations, revealed an increasing level of Previously, we had observed that in wild-type animals integrated cells are often found in small columns glial cell activation in the Crb1 rd8/rd8 mice (Fig. 2D, E) . In wild-type mice, GFAP-positive processes were seen or clusters. While having the appearance of clonal clusters of cells, these groups do not arise from proliferation only occasionally (Fig. 2D , E, far right), and then were largely limited to the peripheral margins of the retina. A of a single donor stem or progenitor cell (24). A possible explanation is that cells migrate into the retina at spesimilar pattern was observed in the 3-week-old Crb1 rd8/ cific locations, such as areas of OLM disruption or at rd8 mice. By 6 weeks GFAP expression was increased and GFAP-positive fibers could be seen extending the site of specific cell types. Upon further examination of the pattern of integration occurring in the Crb1 rd8/rd8 throughout the thickness of the neural retina. Significantly, by 12 weeks GFAP was extensively expressed mice, it was notable that integrated cells were frequently located in large clusters, often of 20-50 cells and somethroughout the retina (Fig. 2E) . Furthermore, Müller cell hypertrophy, seen as processes extending along the outer times hundreds in a group (Fig. 1E ). This was in contrast to the sporadic integration seen in the wild-type retina, edge of the ONL (22), was frequently observed (Fig.  2D, insert) . Thus, the abnormal OLM in the Crb1
where cells are usually found singularly or in small clusters of only 2-5 cells (Fig. 1F) . The spread of integrated mouse leads to a progressive disorganization of the ONL, together with increasing Müller glial cell activacells was not qualitatively significantly different from that observed in wild-type mice (i.e., the majority of tion, with age, which is widespread by 12 weeks. These data suggest that cell integration at 12 weeks may be cells integrating did so around the site of cell injection).
As increased integration levels were seen at earlier adversely affected by the marked glial cell activation. In summary, lack of CRB1 and an abnormal OLM enhance stages in the Crb1 rd8/rd8 mice but declined by 12 weeks, we used immunohistochemistry to assess the level of photoreceptor cell integration, but only at early stages of degeneration prior to widespread glial cell activation. OLM disruption, ONL disorganization, and glial cell ac- Junction Complex
The OLM Can Be Transiently Disrupted Using siRNAs Targeted Against a Component of the Adherens
As cell integration is significantly increased when precursors are transplanted into the Crb1 rd8/rd8 mouse, a ZO-1 (B) , the cell adhesion marker, pancadherin (C), glial fibrilliary acidic protein (GFAP) (D, E), which labels activated astrocytes and glia and vimentin (E), which labels Müller glia regardless of activation (37) . Staining is shown in 3-, 6-, and 12-week-old Crb1 rd8/rd8 mice and 6-week-old wild-type mice. Insets in (A) and (B), single confocal sections from 6-week-old Crb1 rd8/rd8 and wild-type mice showing the fragmented staining pattern (arrows) of ZO-1 and Crb1 in the Crb1 rd8/rd8 mouse. Inset in (D), GFAP staining shows GFAP-positive fibers extending along the edge of the ONL at 12 weeks. GFAP staining increased markedly between 6 and 12 weeks. All images shown are taken from the superior retina. Scale bars: 50 µm and 10µm (insets).
ruption, we designed a strategy for transiently and recontrol siRNA (Fig. 3F, arrows, top) . Conversely, OLM integrity was lost in many regions around the injection versibly disrupting the OLM in the adult retina. A number of reports have demonstrated that siRNAs can site of the ZO-1 siRNA-treated eyes, with significant distances between the remaining adherens junctions produce a knockdown of their target proteins in the eye (6, 32, 38, 44) . Here, we used siRNA targeted against ZO- (Fig. 3F, arrows, bottom) . These findings are further supported by the reduced or disrupted expression of pan-1, one of the adaptor proteins involved in adherens junction formation, and one whose expression was affected cadherin (Fig. 3G) , β-catenin (Fig. 3H) , and Crb1 (Fig.  3I) , in ZO-1 siRNA-treated eyes, compared with only in the Crb1 rd8/rd8 mouse. In order to establish the optimum dose of siRNA relimited disturbance following injection of nontargeting control siRNA or vehicle alone. quired for a transient downregulation of ZO-1 in vivo, several doses (10, 15, and 20 µM) of either ZO-1 siRNA
We next established the time course of ZO-1 knockdown to determine the optimal time for transplanting or a nontargeting control siRNA were administered either via subretinal or intravitreal injection to adult (6) (7) (8) cells following OLM disruption (Fig. 5) . Following subretinal injection of 15 µM ZO-1 siRNA, ZO-1 expresweeks old) wild-type mice. The retinae were then examined via immunohistochemistry at 48 h postinjection sion was reduced between 48 and 72 h postinjection, but had largely recovered by 1 week post-siRNA injection (Fig. 3) . Intravitreal administration failed to affect ZO-1 expression at the OLM (data not shown). Similarly, (Fig. 5A) . Pancadherin (Fig. 5D ) presented a similar pattern of disruption and recovery over the same time subretinal injection of 10 µM siRNA failed to knock down ZO-1, as demonstrated by continuous ZO-1 imcourse. The introduction of vehicle either with or without nontargeting control siRNA causes a transient demunostaining at the OLM (Fig. 3A) . Conversely, ZO-1 staining was discontinuous around the site of detachtachment of the neural retina, but had little obvious effect on OLM integrity, as assessed by ZO-1 (Fig. 5B , C) ment following application of 15 µM siRNA (Fig. 3B) , and largely abolished following application of 20 µM and pancadherin (Fig. 5E, F) expression. Occasionally, localized disruption was seen at 48 h (Fig. 5B , insert, siRNA (Fig. 3C, D) . ZO-1 expression remained intact in the opposite hemisphere, away from the injection site arrow) both in nontargeting and vehicle-injected retinas, but this had largely resolved by 1 week postinjection. (data not shown).
While the highest dose of siRNA was the most effec-GFAP expression was increased compared to uninjected retinas but was similar in each of ZO-1 siRNA-treated, tive at reducing ZO-1 expression, it was also frequently associated with significant levels of cell death in the nontargeting-treated, and vehicle-treated eyes (Fig. 5G-I ). Thus, these changes are most likely due to the physi-ONL 48 h after administration, compared with nontargeting siRNA-injected controls ( Table 2 , Fig. 3E ; p < cal disruption caused by the subretinal detachment itself. These data show that ZO-1 siRNA treatment can 0.05 ANOVA with Bonferroni's correction). By contrast, application of 15 µM ZO-1 siRNA did not lead to achieve a transient, reversible disruption of the OLM in the adult wild-type mouse while maintaining recipient a significant increase in cell death (p > 0.05) ( Table 2 ). The detachment process itself, made with vehicle alone, retina integrity. is also associated with a degree of apoptosis, similar to Increased Rod Photoreceptor Integration that seen following injection of either 15 µM ZO-1
Following OLM Disruption by ZO-1 Knockdown siRNA or nontargeting siRNA (p > 0.05) ( Table 2 ). In in the Wild-Type Mouse each case, apoptotic cells were evenly distributed across the ONL. The level of apoptosis fell significantly by 4 Having determined the time course of OLM disruption, we examined the impact of a transient downregulaweeks postinjection, suggesting that the apoptosis observed was transient and not indicative of an induced tion of ZO-1, and subsequent disruption of the OLM, on cell integration. Wild-type animals received a 1-µl degeneration. ERG recordings were taken at 7 weeks postinjection. There was no significant difference in eiinjection to the superior retina containing either 10, 15, or 20 µM siRNA, 48 h prior to the injection of dissocither a-or b-wave amplitude in eyes treated with ZO-1 siRNA compared with either nontargeting or uninjected ated P4 neural retinal cells (200,000 unsorted cells/µl) to the same region. The contralateral eye received a control controls (Fig. 4A, B) . Thus, ZO-1 siRNA application does not appear to have a detrimental effect on visual injection of nontargeting siRNA, as before, followed by an equivalent cell injection 48 h later. Three weeks after function.
We next sought to confirm that knockdown of ZO-1 cell transplantation, eyes were collected and the retinae were assessed for cell integration (Fig. 6 ). All animals using subretinal injection of 15 µM ZO-1 siRNA conferred disruption to the OLM itself. Electron microscopy receiving either the 20 or 15 µM dose of ZO-1 siRNA demonstrated a significant increase in integration, compared images show that at 48 h post-siRNA administration, the OLM was intact in retinae treated with the nontargeting both with the contralateral, nontargeting siRNA-treated eye and standard control injections (no preinjection) was 11,965, seen following application of 20 µM ZO-1 siRNA. Those eyes receiving nontargeting siRNA (all (Fig. 6A-C, Table 3 ). Cell integration was unchanged by application of 10 µM siRNA compared both with the doses) had significantly higher levels of integration (approximately twofold) than was seen in a standard incorresponding dose of nontargeting siRNA and with wild-type controls (Fig. 6A) . The maximum number of jection in which the animal received no pretreatment (1,842 ± 131 vs. 949 ± 141 cells, combining all nontarintegrated cells observed following siRNA treatment geting data sets; N = 15/N = 13; p < 0.05, unpaired tin the ZO-1 siRNA-treated animals is similar to that observed in the Crb1 rd8/rd8 mouse; cells frequently intetest). We have also found a similar enhancement when combining predetachments made with vehicle alone grated in clusters, perhaps correlating with areas of OLM disruption (Fig. 6D ). Together these data show with subsequent cell transplantation, suggesting that the predetachment process itself leads to a modest but sigthat loss of two different proteins essential for correct adherens junction localisation, CRB1 and ZO-1, ennificant increase in integration (manuscript in preparation). Of note also, is that the pattern of cell integration hances donor cell integration into the ONL. (35, 42, 49) . However, this ability is largely Next we sought to determine whether or not such findings translate to the degenerating retina. The rho −/− lost as the recipient animal matures, whereupon stem cell populations appear able to migrate only when the mouse is a moderately severe model of rod photoreceptor degeneration with almost all rods lost by 3 months recipient retina is damaged in some way (20, 29, 49) . Here, we provide strong evidence demonstrating that the OLM of age (17) . In contrast to previous reports (4,5), we found the OLM to be intact even at late stages of degenof the recipient retina is a physical barrier to donor cell migration and integration and presents a potential target eration (Fig. 7) . Expression of ZO-1, Crb1, and pancadherin were as robust as that seen in wild-type (Fig. for improving transplantation into both the wild-type and, importantly, the degenerating retina. Moreover, we 7A-C). Moreover, assessment at the EM level revealed the adherens junctions to be intact (Fig. 7E) . GFAP was present a novel way of inducing a transient disruption of this barrier that, when combined with cell transplantaalso extensively upregulated, as is typical of degenerating retinas (Fig. 7D) . We therefore examined the impact tion, led to significant improvements in integration in models of retinal degeneration. of OLM disruption on cell integration in this model. One-month-old rho −/− animals received 15 µM ZO-1 Recessive mutations in the human CRB1 gene cause retinal diseases including retinitis pigmentosa and LebsiRNA in one eye and nontargeting control siRNA in the contralateral eye 48 h prior to the injection of cells ers congenital amaurosis (7, 10) . Currently, there is no effective treatment for patients with CRB1 mutations. to the same region. All ZO-1 siRNA-treated animals demonstrated a significant increase in integration, com-
The Crb1 rd8/rd8 mouse has a phenotype similar to human patients with missense CRB1 mutations. We found that pared with both the contralateral, nontargeting siRNAtreated eye and standard rho −/− control injections (no predonor cell migration was significantly improved in these animals compared with wild-type animals and that the injection) (Fig. 6A, Table 3 ).
level of integration increased with increasing OLM dis-DISCUSSION ruption, up to 6 weeks of age. This contrasts with the very low levels of cell integration observed following Cell transplantation for the treatment of neurodegenerative diseases is an area of intense current investigatransplants into other models of retinal degeneration, such as the rho −/− and the Prph2 rd2/rd2 (rds) mouse, where tion. However, transplantation into the mature CNS faces a major hurdle-the limited ability of transplanted typically only a few hundred cells integrate (24). Together these data demonstrate that the OLM presents a cells to survive, migrate, and establish morphological and synaptic connectivity with the recipient tissue.
physical barrier to transplanted cell migration and integration [and it is important to note that the OLM is There has been considerable interest in trying to generate specific cell types for transplantation, but for these likely to be one of a number of such barriers (40)]. Secondly, they show that the degenerative apoptotic envifindings to be successfully translated into clinical thera- ronment itself is unlikely to be promoting transplanted While retinal dystrophies involving CRB1 may prove ideal candidates for cell transplantation therapy, retinal cell integration. Thirdly, the Crb1 rd8/rd8 mouse provides a relevant model of a specific type of retinal dystrophy, degeneration caused by many other gene defects, such as rd1 and rds, is not associated with marked OLM diswhich may be more amenable to cell transplantation therapy than other inherited retinal degenerations.
ruption until very late stages of the disease (12,16,36 ).
This suggests that the OLM might present a significant eyes. Moreover, the cell loss declined with time, unlike the progressive degeneration observed by Yang and colbarrier to transplanted photoreceptor precursor cell migration and integration in the majority of retinal degenleagues. Nonetheless, further work is required to optimize the surgical procedures involved to minimize any erations, particularly at early stages. Therefore, we must seek ways to overcome the physical barrier presented associated cell loss. Of interest is the finding that integration in the 12-by the OLM. The pharmacological induction of OLM disruption by aminoadipic acid (AAA) we have reported week-old Crb1 rd8/rd8 mouse was not significantly better than wild-type controls, despite the continued disruption previously (51) would not be suitable due to detrimental side effects within the recipient retina, including very of the OLM. We also observed very high levels of GFAP and vimentin staining at the edge of the ONL in these significant apoptosis in both the Müller glia and photoreceptor populations (18,30,33) . Furthermore, the overolder animals, with numerous Müller glial processes running along the outer limits of the ONL. This level all increase in integration, while consistently higher than the vehicle-injected eyes, was only similar to that seen and pattern of expression is similar to that seen in 4-6-week-old rho −/− mice and strongly indicative of glial for standard control injections. However, the results presented here suggest that if appropriate methods of OLM scarring. Such scarring is often associated with neural injury and is known to obstruct regenerative processes, disruption are used, significant improvements in cell integration above that previously reported (3, 24) can be such as axonal regrowth, by forming physical and diffusional barriers that separate undamaged regions from the achieved. Moreover, such improvements are also possible in models of retinal degeneration.
area of injury (13, 14, 31) . We propose that in the Crb1
mouse there is a trade-off between the progressive disRNAi strategies have been successfully applied to the treatment of mouse and rat models of hepatitis and canruption of the OLM, permitting increased integration and an increase in glial scarring, ultimately inhibiting cers (25,53). A feature of siRNAs that is that they are typically unstable, being removed by endogenous RNases, cell migration, despite the disruption of the OLM. There is thus a window of opportunity around 6 weeks of age, and so have a short duration of action. The strategy employed here utilized this characteristic and used naked at which cell integration is increased. GFAP expression itself has been both positively and negatively correlated siRNA to demonstrate a proof of principle, namely that the OLM could be reversibly disrupted by siRNAs in with cell migration. Kinouchi and colleagues (19) demonstrated that elimination of both GFAP and vimentin both wild-type and degenerating retinas. ZO-1 was the first tight junction protein identified and functions as a in wild-type mice permitted increased integration following transplantation of retinal progenitor cells. We junctional adaptor that interacts with multiple transmembrane proteins, components of the junctional plaque and have also observed that integration is negatively correlated with increasing gliosis in a number of models of actin filaments (1, 11, 46) . Because ZO-1 is also expressed at the tight junctions of the RPE, it is possible degeneration (A.C.B and R.A.P, unpublished observations). Conversely, Perez and colleagues (54, 55) suggest that a subretinal injection of ZO-1 siRNA will also impact on these junctions, although we did not observe any that cells migrate at sites of GFAP upregulation following transplantation of fetal retinal sheets. Here, we obobvious signs of leakiness or oedema. For this strategy to be taken forward, it is therefore important to identify served similar levels of glial cell activation, as indicated by GFAP staining, following application of either ZO-1 other targets for siRNAs that may have less impact on the overlying RPE tight junctions. Recent work suggests siRNA, nontargeting siRNA, or vehicle alone, but integration was only significantly improved those eyes rethat there are differences in the expression of tight junction proteins in the RPE compared with the adherens ceiving the ZO-1 siRNA. Similarly, integration was significantly lower in control rho −/− mice, a model in which junctions of the OLM (8), which may provide alternative targets. Indeed, Crb1 itself is worthy of further considergliosis is prominent, and only enhanced in animals receiving ZO-1 siRNA. Together with the findings from ation, because its expression in the eye is restricted to the OLM (9) .
the Crb1 rd8/rd8 mouse and the AAA work reported previously, these results point strongly towards the imAlthough ZO-1 proved an effective target for inducing reversible OLM disruption here, high concentrations provements being as a result of OLM disruption. However, it is important to remember that it is highly unlikely were associated with a moderate level of cell death. Recently, Yang and colleagues demonstrated that doublethat any one single barrier is responsible for preventing transplanted cell integration per se. Thus, any effective stranded RNAs greater than 21 nucleotides can bind with the Toll-Like receptor 3 (TLR3) and induce apotherapeutic treatment must encompass a number of different factors, including the reduction of reactive gliosis ptosis (52) . It is unlikely that the apoptosis observed in this study was due to interactions with TLR3, because and subsequent glial scarring and transient disruption of the OLM. the levels observed were similar in both the siRNAtreated (targeting and nontargeting) and vehicle-treated
In conclusion, we have provided strong evidence that 
